Position
Squarepoint Ops LLC in Agios Pharmaceuticals, Inc.
Back to the book · All holders of AGIO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $804.9K$27.22 → $33.83
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 121.8K | $3.31M | — | — | — | 0.0% |
| Q1 2026 | 208.9K | $7.07M | $33.83 | $804.9K | $2.95M | 0.0% |